Prolonged, low-level inhalation of the common weed-killer paraquat, implicated in the risk of Parkinson’s disease, caused male mice to lose at least some of their sense of smell, a study reports. This work also supported previous studies showing the inhaled chemical enters the brain via the olfactory nerve.
News
A scientist at the University of Latvia claimed a journal’s Young Investigator Award for her research showing how small vesicles derived from stem cells could lessen motor symptoms in a rat model of Parkinson’s disease. Karīna Narbute’s work establishes a proof of concept for the potential of small vesicles —…
Gocovri (amantadine) has been approved by the U.S. Food and Drug Administration (FDA) as an add-on therapy for off episodes in people with Parkinson’s disease. Adamas Pharmaceuticals, which developed the therapy, announced its approval in the U.S. for Parkinson’s patients currently taking levodopa and/or carbidopa. Off…
Eisai Korea has launched Equfina (safinamide) in South Korea as an add-on therapy to levodopa for people with Parkinson’s disease who are experiencing “off” episodes. Equfina was approved in South Korea last year and this represents the medication’s first launch in Asia outside of Japan. Marketed as Xadago…
Brain Neurotherapy Bio (BNB) has joined with Asklepios BioPharmaceutical (AskBio), a merger aiming to expand a gene therapy program for progressive neurodegenerative diseases such as Parkinson’s and multiple system atrophy (MSA), a form of atypical parkinsonism. “I’m pleased to welcome the Brain Neurotherapy Bio team to AskBio,” Sheila…
New guidelines published by The British Psychological Society highlight the lack of mental health research and services for people living with Parkinson’s disease and other neurodegenerative conditions, and offers evidence-based recommendations for health professionals to help better serve patients. “We hope that our guidelines will add to…
Scientists have found that the Hoffmann reflex — a test often used to evaluate reflexes in the upper extremities — can be used as a biomarker to assess the correct placement of electrodes during deep brain stimulation (DBS) surgery in patients with advanced Parkinson’s disease. This reflex test,…
A survey done in Germany showed that a majority of people with Parkinson’s disease were interested in exploring medical cannabis as a treatment option, with those already using it reporting positive effects. Notably, most non-users indicated that a lack of knowledge, and the fear of side effects, had stopped…
Manus Neurodynamica, a medical technology company, has raised £1.2 million ($1.6 million) to launch NeuroMotor, a digital pen with a patented sensor technology that can help diagnose patients with Parkinson’s disease and other movement disorders. This financing round will allow the NeuroMotor Pen to be launched in…
Microba has partnered with researchers at the University of Queensland’s (UQ) Faculty of Medicine to study gut bacteria of people with Parkinson’s disease, with a goal of discovering and developing new biomarkers and therapies for this neurodegenerative disorder. A first clinical trial is planned for this year at sites…
Recent Posts
- Deep brain stimulation was a lifesaver for my husband with Parkinson’s
- Me and Mary Jane: My one experience trying marijuana for Parkinson’s
- Low muscle mass is more common in early-stage Parkinson’s disease
- Guest Voice: What de facto parenting can teach us about Parkinson’s
- Parkinson’s advocates urge implementation of new federal plan